Effect of Kalonji in Polycystic Ovary
Phase 2
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2024/07/071331
- Lead Sponsor
- State TakmeelutTib College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Married & Unmarried females 18 years and above
Rotterdam criteria (any two out of three)
Clinical or biochemical hyperandrogenism
Evidence of oligo-anovulation
Polycystic appearing-ovarian morphology on Ultrasound
BMI above 25kg per meter square
Exclusion Criteria
Pregnant lactating and menopausal women
Patients with systemic and other endocrinal illness
History of malignancy
Patients with other pelvic pathology
Patients on oral contraceptive pills and IUCDs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Regulation of menstrual cycle <br/ ><br>Change in polycystic ovarian morphology in USGTimepoint: 90 days
- Secondary Outcome Measures
Name Time Method Weight reduction Reduction in BMI <br/ ><br>Decreased Waist to Hip Ratio <br/ ><br>Lipid profile <br/ ><br>Decreases clinical sign of androgen excess Ferriman Gallwey score <br/ ><br>Decrease in Acanthosis nigricans score <br/ ><br>Conception rate in married femalesTimepoint: 90 days